Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) announced that the third joint meeting of the third session of its employee representative meeting, held on 16 June 2026, elected Mr. Zhao Yong as employee-representative director for the company’s ninth Board session. The appointment is effective immediately and aligns with the tenure of the new Board; shareholder approval is not required under Hong Kong Listing Rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments